Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
Market Watch, The Wall Street Journal, 27 May 2014
Accessed on 29 May 2014 from http://www.marketwatch.com/story/mapi-pharma-receives-additional-claims-for-its-us-patent-for-glatiramer-acetate-depot-for-the-treatment-of-multiple-sclerosis-2014-05-27.
